Literature DB >> 29726777

Surgical outcomes after reoperation for recurrent skull base meningiomas.

Stephen T Magill1, David S Lee1, Adam J Yen1, Calixto-Hope G Lucas1, David R Raleigh2, Manish K Aghi1, Philip V Theodosopoulos1, Michael W McDermott1.   

Abstract

OBJECTIVE: Skull base meningiomas are surgically challenging tumors due to the intricate skull base anatomy and the proximity of cranial nerves and critical cerebral vasculature. Many studies have reported outcomes after primary resection of skull base meningiomas; however, little is known about outcomes after reoperation for recurrent skull base meningiomas. Since reoperation is one treatment option for patients with recurrent meningioma, the authors sought to define the risk profile for reoperation of skull base meningiomas.
METHODS: A retrospective review of 2120 patients who underwent resection of meningiomas between 1985 and 2016 was conducted. Clinical information was extracted from the medical records, radiology data, and pathology data. All records of patients with recurrent skull base meningiomas were reviewed. Demographic data, presenting symptoms, surgical management, outcomes, and complications data were collected. Kaplan-Meier analysis was used to evaluate survival after reoperation. Logistic regression was used to evaluate for risk factors associated with complications.
RESULTS: Seventy-eight patients underwent 100 reoperations for recurrent skull base meningiomas. Seventeen patients had 2 reoperations, 3 had 3 reoperations, and 2 had 4 or more reoperations. The median age at diagnosis was 52 years, and 64% of patients were female. The median follow-up was 8.5 years. Presenting symptoms included cranial neuropathy, headache, seizure, proptosis, and weakness. The median time from initial resection to first reoperation was 4.4 years and 4.1 years from first to second reoperation. Seventy-two percent of tumors were WHO grade I, 22% were WHO grade II, and 6% were WHO grade III. The sphenoid wing was the most common location (31%), followed by cerebellopontine angle (14%), cavernous sinus (13%), olfactory groove (12%), tuberculum sellae (12%), and middle fossa floor (5%). Forty-four (54%) tumors were ≥ 3 cm in maximum diameter at the time of the first reoperation. In 100 reoperations, 60 complications occurred in 30 cases. Twenty of the 60 complications required surgical intervention (33%). Complications included hydrocephalus (12), CSF leak/pseudomeningocele (11), wound infection (9), postoperative hematoma (4), venous infarction (1), and pneumocephalus (1). Postoperative neurological deficits included new or worsened cranial nerve deficits (10) and hemiparesis (3). There were no perioperative deaths in this series. On multivariate analysis, posterior fossa location was significantly associated with complications (OR 3.45, p = 0.0472). The 1-, 2-, 5-, and 10-year overall survival rates according to Kaplan-Meier analysis after the first reoperation were 94%, 92%, 88%, and 76%, respectively. The median survival after the first reoperation was 17 years.
CONCLUSIONS: Recurrent skull base meningiomas are surgically challenging tumors, and reoperation is associated with high morbidity and complication rates. Despite these cautionary data, repeat resection of recurrent skull base meningiomas in appropriately selected patients provides excellent long-term survival.

Entities:  

Keywords:  EBRT = external-beam radiotherapy; EMR = electronic medical record; complications; meningioma; recurrence; reoperation; repeat operation; risk factor; skull base; surgery

Mesh:

Year:  2018        PMID: 29726777     DOI: 10.3171/2017.11.JNS172278

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

Review 1.  The Role of Surgery in Meningiomas.

Authors:  Michele Bailo; Filippo Gagliardi; Nicola Boari; Antonella Castellano; Alfio Spina; Pietro Mortini
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.598

Review 2.  Multimodality Therapy of Patients with Refractory Meningiomas.

Authors:  Haroon Ahmad; David Schiff
Journal:  Curr Treat Options Oncol       Date:  2019-05-09

3.  Consensus core clinical data elements for meningiomas (v2021.1).

Authors:  Farshad Nassiri; Justin Z Wang; Karolyn Au; Jill Barnholtz-Sloan; Michael D Jenkinson; Kate Drummond; Yueren Zhou; James M Snyder; Priscilla Brastianos; Thomas Santarius; Suganth Suppiah; Laila Poisson; Francesco Gaillard; Mark Rosenthal; Timothy Kaufmann; Derek S Tsang; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  Small Cerebellopontine Angle Meningioma-Surgical Experience of 162 Patients and Literature Review.

Authors:  Jiyuan Bu; Pengjie Pan; Hui Yao; Weiyi Gong; Yuan Liu; Zhengquan Yu; Zhong Wang; Jiang Wu; Gang Chen
Journal:  Front Oncol       Date:  2020-10-09       Impact factor: 6.244

5.  Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.

Authors:  Michael A Mooney; Wenya Linda Bi; Jonathan M Cantalino; Kyle C Wu; Thomas C Harris; Lucas L Possatti; Parikshit Juvekar; Liangge Hsu; Ian F Dunn; Ossama Al-Mefty; Phillip M Devlin
Journal:  J Neurooncol       Date:  2019-11-19       Impact factor: 4.130

6.  Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.

Authors:  Soichi Oya; Fusao Ikawa; Nao Ichihara; Masahiko Wanibuchi; Yukinori Akiyama; Hirofumi Nakatomi; Nobuhiro Mikuni; Yoshitaka Narita
Journal:  J Neurooncol       Date:  2021-05-17       Impact factor: 4.130

7.  Hydrocephalus Following Giant Transosseous Vertex Meningioma Resection.

Authors:  Bradley T Schmidt; Ulas Cikla; Abdulbaki Kozan; Robert J Dempsey; Mustafa K Baskaya
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-14

8.  Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas.

Authors:  Yuki Kuranari; Ryota Tamura; Noboru Tsuda; Kenzo Kosugi; Yukina Morimoto; Kazunari Yoshida; Masahiro Toda
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

Review 9.  Health-related quality of life in meningioma.

Authors:  Sameah Haider; Martin J B Taphoorn; Katharine J Drummond; Tobias Walbert
Journal:  Neurooncol Adv       Date:  2021-06-26

10.  Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma.

Authors:  Stephen T Magill; Harish N Vasudevan; Kyounghee Seo; Javier E Villanueva-Meyer; Abrar Choudhury; S John Liu; Melike Pekmezci; Sarah Findakly; Stephanie Hilz; Sydney Lastella; Benjamin Demaree; Steve E Braunstein; Nancy Ann Oberheim Bush; Manish K Aghi; Philip V Theodosopoulos; Penny K Sneed; Adam R Abate; Mitchel S Berger; Michael W McDermott; Daniel A Lim; Erik M Ullian; Joseph F Costello; David R Raleigh
Journal:  Nat Commun       Date:  2020-09-23       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.